市場調査レポート

商品コード

新生児スクリーニングの市場規模および動向、世界および地域シェア、動向、成長機会分析レポート対象範囲：製品タイプ別、技術別、検査タイプ別、エンドユーザー別、地域別

Newborn Screening Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type, Technology, Test Type, End User, and Geography

出版日: 2023年09月28日
発行: The Insight Partners
ページ情報: 英文 226 Pages
納期: 即納可能

価格

PDF (Single User License)

USD 4,450 653,349円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 6,450 946,989円

レポートPDFを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 8,450 1,240,629円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.82円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の新生児スクリーニング市場は、2022年の12億600万米ドルから2030年には24億8,400万米ドルに達すると予測されています。同市場は2022年から2030年にかけてCAGR 9.4％で成長すると推定されます。

市場を牽引する主な要因としては、先天性疾患の負担増と新生児疾患の有病率の増加が挙げられます。しかし、新生児スクリーニングの方針と手順が世界的に統一されていないことや、偽陽性・偽陰性の結果が市場成長の妨げとなっています。

新生児スクリーニング市場の市場機会

病状の遺伝的原因に関する知識の深まりやヘルスケア技術の進歩に伴い、新生児の包括的な遺伝子スクリーニングの需要が高まっています。その結果、新生児スクリーニング市場の企業は、革新的で費用対効果の高いスクリーニング・ソリューションを開発しています。米国FDAは2017年、特定の種類の急性リンパ芽球性白血病の小児患者に使用するためのKymriah遺伝子治療を認可しました。この治療では、キメラ抗原受容体をコードする新しい遺伝子が患者のT細胞に挿入され、変化したT細胞を刺激して白血病細胞を追いかけて破壊します。イエスカルタとジンテグロは、大細胞型B細胞リンパ腫とβ-サラセミアに対して認可された遺伝子治療の2つの例です。さらに、出生時に疾患の遺伝的素因を特定できる技術の出現は、個別化ヘルスケアの道を開き、精密医療という広範な動向と一致します。

妊娠中の遺伝性疾患のスクリーニングは、妊娠に関連する問題の早期発見にも重点を置いています。次世代シーケンサーは、すべての染色体における異数体（ダウン症候群やトリソミー21など）や部分的な染色体異常（重複や欠失）の検出において95％以上の感度で新生児の出生前スクリーニングを支援します。蛍光in-situハイブリダイゼーション（FISH）は、鎌状赤血球貧血のような単発性疾患を検出するために使用されます。母体血漿を用いた無細胞胎児DNAアプローチのような非侵襲的手順は、遺伝子検査における最近の進歩です。胚DNAはその大きさの違いから母体DNA片と区別することができます。蛍光プローブを用いたリアルタイムPCR、ショットガンシーケンス（SolexaまたはIllumina）、あるいは巨大なターゲットパラレルシーケンスを用いて、胎児の病状に関連するDNAを調べることができます。これにより、この種の遺伝子スクリーニングがさらに研究されれば、医師は特定の薬理療法（薬理遺伝学）による早期の分子的介入を行ったり、細胞、組織、臓器を物理的、化学的に変化させたりすることができるようになります。このように、乳児の遺伝性疾患スクリーニング法の進歩は、新生児スクリーニング市場全体にとって計り知れない可能性を秘めています。

新生児スクリーニング市場を阻害する要因

国によってスクリーニングされる疾患のリストが異なるため、新生児スクリーニングの政策や実施方法が世界的に統一されていないです。包括的な疾患のスクリーニングを行う国もあれば、限られた疾患に焦点を当てる国もあります。この違いは、スクリーニング検査や技術を開発する企業にとって障壁となり、特定の市場に合わせて製品を変更する必要があるため、規模の経済が制限されます。さらに、標準化されたプロトコルがないため、品質管理やデータ収集に一貫性がないです。これは、スクリーニング結果の不正確さや、地域間のデータ比較の難しさにつながり、研究者やヘルスケアプロバイダーにとって、調査対象地域で実施されているスクリーニングプログラムの有効性を評価することを困難にしています。さらに、普遍的な基準がないため、新生児スクリーニング市場で事業を展開する企業にとっては規制状況が複雑となります。各国の承認を得るためには、複雑な規制の網を遵守することに注力する必要があり、時間とコストがかかります。統一性の欠如はまた、国際的な共同研究やデータ共有の妨げとなり、新生児スクリーニング研究と技術開発の可能性を制限します。このように、新生児スクリーニングの政策と手順が統一されていないことが、新生児スクリーニング市場の進展を制限しています。

新生児スクリーニング市場セグメント別概要

新生児スクリーニング市場は、製品タイプ別に試薬・アッセイキットと機器に区分されます。2022年には、試薬およびアッセイキット部門がより大きな市場シェアを占め、今後数年間で最も速い速度で成長すると予想されます。新生児スクリーニング用のさまざまな試薬およびアッセイキットは、DNAベースのアッセイ、免疫アッセイ、酵素アッセイに分類されます。新興国市場では様々な企業が新生児スクリーニング専用の試薬やアッセイキットを開発しています。まず、Labsystems Diagnostics社は、新生児のフェニルアラニンレベルが上昇すると知的障害を引き起こす可能性があるため、フェニルアラニン含有量に基づいて新生児のフェニルケトン尿症（PKU）を検出するための蛍光マイクロプレートベースのアッセイを発売しました。当社が提供する試薬キットはすべて、手動モジュラーシステムまたは全自動ハンズオフシステムです。

新生児スクリーニング市場は、技術別にタンデム質量分析（TMS）、分子アッセイ、免疫アッセイ、酵素アッセイ、パルスオキシメトリー・スクリーニング技術、その他の技術に区分されます。2022年には、パルスオキシメトリースクリーニング技術分野が市場で最大のシェアを占めました。さらに、イムノアッセイおよび酵素アッセイ分野は、今後数年間で最も急速に成長すると予想されています。先天性心疾患（CCHD）は、最も一般的な先天性障害の1つで、管依存性の先天性心疾患です。出生前や出生後に発見されることもあるが、新生児期や乳児期に未診断・未治療の場合、生命を脅かすこともあります。パルスオキシメトリーによるスクリーニングは、乳児の重篤なCCHDを発見するために用いられます。痛みを伴わず、非侵襲的で、費用対効果の高い乳児スクリーニング法です。パルスオキシメーターによるスクリーニングは、血液中のヘモグロビンが酸素で飽和している割合を決定します。

新生児スクリーニング市場は、検査タイプ別に、乾燥血液スポット検査、聴覚スクリーン検査、重症先天性心疾患検査、その他の検査に区分されます。2022年には、血液スポット検査部門が市場で最大のシェアを占めました。同セグメントの新生児スクリーニング市場は、2022～2030年に大幅なCAGRで成長すると推定されます。

新生児スクリーニング市場は、エンドユーザー別に病院、診療所、診断研究所に区分されます。2022年には、病院・診療所セグメントが大きな市場シェアを占めています。しかし、病院・診療所セグメントは、2022-2030年にCAGRで成長すると推定されます。医療提供者は、病院の部屋または新生児・授乳室で新生児スクリーニング検査を実施します。病院・診療所セグメントは、これらの施設が新生児スクリーニングのために最大限の患者数を受け入れていることから、今後数年間は新生児スクリーニング市場でより大きなシェアを占めると予測されています。より良い施設、さまざまな治療オプションの利用可能性、一つ屋根の下での優れた看護ケアは、さまざまな診断および治療手順のために患者をこれらの施設に引きつける。

新生児スクリーニング市場地理的概要

北米の新生児スクリーニング市場は、近年著しい成長を遂げています。先天性障害を特定し管理するための早期スクリーニングの重要性に対する両親やヘルスケア専門家の意識の高まりに伴い、新生児スクリーニングサービスに対する需要が大幅に増加しています。さらに、医療技術の向上は新生児スクリーニングの能力を高める上で極めて重要であり、検査室の自動化はスクリーニングの精度、スピード、費用対効果を高めています。これによって医療専門家は、より広範な遺伝・代謝疾患をカバーする徹底した新生児スクリーニング・パネルを提供できるようになっています。有利な法律や規制措置も北米の新生児スクリーニング市場に利益をもたらしています。多くの州や州が新生児スクリーニングの義務化プログラムを実施しており、すべての乳児が出生直後にスクリーニングを受けられるようになっています。例えば、米国では各州が公衆衛生プログラムとして新生児スクリーニングを実施しており、年間約400万人の乳児がこのプログラムの下で出産時にはあまり見られない病気のスクリーニングを受けています。テキサス州保健福祉局は2021年6月、脊髄性筋萎縮症（SMA）の新生児スクリーニングを開始しました。

新生児スクリーニング市場に関する報告書を作成する際に参照した主な一次情報および二次情報は、世界銀行データ、国民保健サービス（NHS）、FDA（食品医薬品局）、EMA（欧州医薬品庁）、WHO（世界保健機関）です。

市場促進要因
- 新生児スクリーニングに対する政府資金の急増
- 先天性疾患の負担増加
- 新生児疾患の有病率の増加
主な市場抑制要因
- 新生児スクリーニングの政策と実施における統一性の欠如
主な市場機会
- 新生児の遺伝子スクリーニング
今後の動向
- スクリーニングにおける機械学習と人工知能の統合
インパクト分析

第6章新生児スクリーニング市場：世界市場分析

新生児スクリーニング市場の収益、2022年～2030年

第7章新生児スクリーニングの世界市場：収益と2030年までの予測：製品タイプ別

新生児スクリーニング市場の製品タイプ別収益シェア（2022年・2030年）
試薬およびアッセイキット
インストルメンツ

第8章新生児スクリーニングの世界市場：収益と2030年までの予測：技術別

新生児スクリーニング市場の収益シェア、技術別、2022年および2030年（%）
タンデム質量分析（TMS）
分子アッセイ
免疫アッセイおよび酵素アッセイ
パルスオキシメトリー・スクリーニング技術
その他の技術

第9章新生児スクリーニングの世界市場：2030年までの収益と予測：検査タイプ別

新生児スクリーニング市場の2022年および2030年における収益シェア（検査タイプ別）
乾燥血液スポット検査
聴覚スクリーニング検査
重症先天性心疾患（CCHD）検査
その他の検査タイプ

第10章新生児スクリーニングの世界市場：エンドユーザー別収益と2030年までの予測

新生児スクリーニング市場のエンドユーザー別収益シェア（2022年・2030年）
病院および診療所
診断研究所

第11章新生児スクリーニング市場：地域別分析

北米
- メキシコ
欧州
- その他欧州
アジア太平洋
- その他アジア太平洋地域
中東・アフリカ
- その他中東とアフリカ
中南米
- その他中南米

第12章新生児スクリーニング市場-業界情勢

新生児スクリーニング市場における成長戦略
有機的成長戦略
無機的成長戦略

第13章企業プロファイル

LifeCell International Pvt Ltd
Zentech SA
Trivitron Healthcare Pvt Ltd
PerkinElmer Inc
Waters Corp
Bio-Rad Laboratories Inc
Masimo Corp
Natus Medical Inc.
Baebies Inc
MRC Holland BV
Medtronic Plc

第14章付録

図表

List Of Tables

Table 1. Newborn Screening Market Segmentation
Table 2. Global Newborn Screening Market, by Reagents and Assay Kits - Revenue and Forecast to 2030 (US$ Million)
Table 3. Global Newborn Screening Market, by Instruments - Revenue and Forecast to 2030 (US$ Million)
Table 4. North America Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 5. North America Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 6. North America Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 7. North America Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 8. North America Newborn Screening Market, by Test Type- Revenue and Forecast to 2030 (US$ Million)
Table 9. North America Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 10. US Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 11. US Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 12. US Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 13. US Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 14. US Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 15. US Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 16. Canada Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 17. Canada Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 18. Canada Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 19. Canada Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 20. Canada Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 21. Canada Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 22. Mexico Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 23. Mexico Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 24. Mexico Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 25. Mexico Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 26. Mexico Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 27. Mexico Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 28. Europe Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 29. Europe Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 30. Europe Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 31. Europe Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 32. Europe Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 33. Europe Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 34. UK Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 35. UK Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 36. UK Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 37. UK Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 38. UK Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 39. UK Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 40. Germany Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 41. Germany Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 42. Germany Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 43. Germany Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 44. Germany Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 45. Germany Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 46. France Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 47. France Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 48. France Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 49. France Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 50. France Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 51. France Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 52. Italy Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 53. Italy Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 54. Italy Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 55. Italy Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 56. Italy Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 57. Italy Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 58. Spain Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 59. Spain Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 60. Spain Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 61. Spain Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 62. Spain Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 63. Spain Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 64. Rest of Europe Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 65. Rest of Europe Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 66. Rest of Europe Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 67. Rest of Europe Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 68. Rest of Europe Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 69. Rest of Europe Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 70. Asia Pacific Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 71. Asia Pacific Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 72. Asia Pacific Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 73. Asia Pacific Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 74. Asia Pacific Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 75. Asia Pacific Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 76. China Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 77. China Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 78. China Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 79. China Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 80. China Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 81. China Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 82. Japan Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 83. Japan Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 84. Japan Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 85. Japan Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 86. Japan Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 87. Japan Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 88. India Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 89. India Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 90. India Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 91. India Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 92. India Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 93. India Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 94. Australia Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 95. Australia Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 96. Australia Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 97. Australia Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 98. Australia Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 99. Australia Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 100. South Korea Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 101. South Korea Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 102. South Korea Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 | (US$ Million)
Table 103. South Korea Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 104. South Korea Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 105. South Korea Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 106. Rest of Asia Pacific Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 107. Rest of Asia Pacific Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 108. Rest of Asia Pacific Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 109. Rest of Asia Pacific Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 110. Rest of Asia Pacific Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 111. Rest of Asia Pacific Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 112. Middle East & Africa Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 113. Middle East & Africa Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 114. Middle East & Africa Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 115. Middle East & Africa Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 116. Middle East & Africa Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 117. Middle East & Africa Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 118. Saudi Arabia Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 119. Saudi Arabia Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 120. Saudi Arabia Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 121. Saudi Arabia Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 122. Saudi Arabia Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 123. Saudi Arabia Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 124. UAE Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 125. UAE Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 126. UAE Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 127. UAE Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 128. UAE Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 129. UAE Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 130. South Africa Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 131. South Africa Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 132. South Africa Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 133. South Africa Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 134. South Africa Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 135. South Africa Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 136. Rest of Middle East & Africa Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 137. Rest of Middle East & Africa Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 138. Rest of Middle East & Africa Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 139. Rest of Middle East & Africa Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 140. Rest of Middle East & Africa Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 141. Rest of Middle East & Africa Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 142. South & Central America Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 143. South & Central America Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 144. South & Central America Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 145. South & Central America Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 146. South & Central America Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 147. South & Central America Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 148. Brazil Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 149. Brazil Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 150. Brazil Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 151. Brazil Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 152. Brazil Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 153. Brazil Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 154. Argentina Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 155. Argentina Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 156. Argentina Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 157. Argentina Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 158. Argentina Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 159. Argentina Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 160. Rest of South & Central America Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 161. Rest of South & Central America Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 162. Rest of South & Central America Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
Table 163. Rest of South & Central America Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 164. Rest of South & Central America Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 165. Rest of South & Central America Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 166. Recent Organic Growth Strategies in Newborn Screening Market
Table 167. Recent Inorganic Growth Strategies in the Newborn Screening Market
Table 168. Glossary of Terms, Newborn Screening Market

List Of Figures

Figure 1. Newborn Screening Market Segmentation, By Geography
Figure 2. Global - PEST Analysis
Figure 3. Newborn Screening Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Newborn Screening Market Revenue (US$ Mn), 2022 - 2030
Figure 6. Newborn Screening Market Revenue, Geography (US$ Mn), 2022 - 2030
Figure 7. Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
Figure 8. Reagents and Assay Kits: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Instruments: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 11. Tandem Mass Spectrometry (TMS): Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Molecular Assays: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Immunoassays and Enzymatic Assays: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Pulse Oximetry Screening Technology: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Other Technologies: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
Figure 17. Dry Blood Spot Test: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Hearing Screen Test: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Critical Congenital Heart Diseases (CCHD) Test: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Other Test Types: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 22. Hospitals and Clinics: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Diagnostic Laboratories: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. North America: Newborn Screening Market, by Key Country - Revenue (2022) (US$ Million)
Figure 25. North America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. North America Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
Figure 27. US Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Canada Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Mexico Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Europe Newborn Screening Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 31. Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. Europe Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
Figure 33. UK Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 34. Germany Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. France Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 36. Italy Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 37. Spain Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 38. Rest of Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 39. Asia Pacific Newborn Screening Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 40. Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 41. Asia Pacific Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
Figure 42. China Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 43. Japan Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 44. India Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 45. Australia Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 46. South Korea Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 47. Rest of Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 48. Middle East & Africa Newborn Screening Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 49. Middle East & Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 50. Middle East & Africa Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
Figure 51. Saudi Arabia Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 52. UAE Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 53. South Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 54. Rest of Middle East & Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 55. South & Central America Newborn Screening Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 56. South & Central America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 57. South & Central America Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
Figure 58. Brazil Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 59. Argentina Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 60. Rest of South & Central America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 61. Growth Strategies in Newborn Screening Market

Product Code: TIPHE100001294

The global newborn screening market is expected to reach US$ 2.484 billion in 2030 from US$ 1.206 billion in 2022. The market is estimated to grow with a CAGR of 9.4% from 2022 to 2030.

The key factors driving the market include rising burden of congenital diseases and increasing prevalence of newborn disorders. However, lack of uniformity of newborn screening policies and procedures across the world and false positive and false negative results hinders the market growth.

Market Opportunities of Newborn Screening Market

The demand for comprehensive genetic screening of newborns is rising with the deepening knowledge about the genetic causes of medical conditions and advancements in healthcare technologies. As a result, companies in the newborn screening market are developing innovative, cost-effective screening solutions. The US FDA licensed the Kymriah gene therapy in 2017 for use in pediatric patients with a particular kind of acute lymphoblastic leukemia. During this therapy, a new gene that codes for a chimeric antigen receptor is inserted into the patient's T cells, stimulating the altered T cells to go after and destroy the leukemic cells. Yescarta and Zynteglo are two more examples of authorized gene treatments for large B-cell lymphoma and beta-thalassemia. Further, the emergence of technologies conferring an ability to identify genetic predispositions to diseases at birth pave the way for personalized healthcare, aligning with the broader trend of precision medicine.

Screening for genetic diseases during pregnancy also focuses on the early detection of pregnancy-related problems. Next-generation sequencing aids in the prenatal screening of neonates with a sensitivity of above 95% for detecting aneuploidies (such as Down syndrome and Trisomy 21) or partial chromosomal abnormalities (duplications or deletions) in all chromosomes. Fluorescence in-situ hybridization (FISH) is employed to detect monogenic illnesses such as sickle cell anemia; it also aids in an effective preimplantation genetic diagnosis. Noninvasive procedures such as the cell-free fetal DNA approach using maternal plasma are the recent advancements in genetic tests. The embryonic DNA can be distinguished from maternal DNA pieces based on differences in their sizes. Real-time PCR with fluorescent probes, shotgun sequencing (Solexa or Illumina), or huge targeted parallel sequencing can be used to examine DNA associated with fetal medical conditions. This would allow doctors to provide early molecular interventions with certain pharmacological therapies (pharmacogenetics) and to transform cells, tissues, and organs physically and chemically if this type of genetic screening is further researched. Thus, advancements in methods for screening infants for genetic disorders hold immense potential for the overall newborn screening market.

Factors Hampering Newborn Screening Market

Variations regarding the list of conditions screened for in different countries result in non-uniformity in newborn screening policies and practices worldwide. A few nations screen for a comprehensive range of disorders, while others focus on a limited set. This difference creates barriers for companies developing screening tests and technologies, as they need to modify their products to specific markets, limiting economies of scale. Moreover, the lack of standardized protocols can result in inconsistent quality control and data collection practices. This leads to inaccuracies in screening results and difficulties in comparing data between regions, making it challenging for researchers and healthcare providers to assess the effectiveness of screening programs implemented in localities understudy. Additionally, the absence of universal standards complicates the regulatory landscape for companies operating in the newborn screening market, as they need to focus on complying with a complex web of regulations for seeking approvals in different countries, which can be time-consuming and expensive. The lack of uniformity can also hinder international collaborations and data sharing, limiting the potential of newborn screening research and technology development. Thus, the lack of uniformity in newborn screening policies and procedures limits the progress of the newborn screening market.

Newborn Screening Market: Segmental Overview

The newborn screening market, by product type, is segmented into reagents and assay kits and instruments. In 2022, the reagents and assay kits segment held a larger market share and is expected to grow at the fastest rate in the coming years. Different reagents and assay kits for newborn screening are categorized into DNA-based assays, immunoassays, and enzymatic assays. Various companies in the market have developed a range of reagents and assay kits specifically for neonatal screening. Firstly, Labsystems Diagnostics launched a fluorometric microplate-based assay for detecting phenylketonuria (PKU) in newborns based on phenylalanine content, as increasing the phenylalanine level in the baby can cause intellectual disability. All the reagent kits offered by the Company are manual modular systems or fully automated hands-off systems.

The newborn screening market, by technology, is segmented into tandem mass spectrometry (TMS), molecular assays, immunoassays and enzymatic assays, pulse oximetry screening technology, and other technologies. In 2022, the pulse oximetry screening technology segment held the largest share of the market. Moreover, the immunoassays and enzymatic assays segment is expected to grow fastest during the coming years. Congenital heart disease (CCHD), one of the most common congenital disabilities, is a duct-dependent congenital heart disease. It may be detected during the prenatal and postnatal period, while it can be life-threatening if it goes undiagnosed and untreated in the neonatal period or infancy. Pulse oximetry screening is used to detect critical CCHD in infants. It is a painless, noninvasive, and cost-effective method of screening infants. The pulse oximeter screening determines the percentage of hemoglobin in the blood saturated with oxygen.

The newborn screening market, by test type, is segmented into dry blood spot tests, hearing screen tests, critical congenital heart disease tests, and other tests. In 2022, the blood spot test segment held the largest share of the market. The newborn screening market for the same segment is estimated to grow at a significant CAGR during 2022 -2030.

The newborn screening market, by end-user, is segmented into hospitals, clinics, and diagnostic laboratories. In 2022, the hospitals and clinics segment held a larger market share. However, the hospitals and clinics segment is estimated to grow at a CAGR during 2022-2030. healthcare provider performs newborn screening tests in a room or a newborn/nursery area at hospitals. The hospitals and clinics segment is projected to hold a larger share of the newborn screening market in the coming years as these facilities receive maximum patient footfall for newborn baby screening. Better facilities, and the availability of different treatment options and good nursing care under one roof attract patients toward these facilities for different diagnostic and therapeutic procedure.

Newborn Screening Market: Geographical Overview

The newborn screening market in North America has experienced significant growth in recent years. The demand for newborn screening services has increased significantly with the surging awareness among parents and healthcare professionals about the importance of early screening for identifying and managing congenital disorders. Additionally, improvements in medical technology have been crucial in enhancing newborn screening capabilities-laboratory automation has boosted screening accuracy, speed, and cost-effectiveness. This has made it possible for medical professionals to give thorough newborn screening panels that cover a larger spectrum of genetic and metabolic disorders. Favorable legislation and regulatory measures also benefit the newborn screening market in North America. Many states and provinces have implemented mandatory newborn screening programs, ensuring all infants are screened shortly after birth. For instance, every state in the US offers newborn screening as a public health program; yearly, ~4 million babies are screened under this program for illnesses that aren't often present at the time of delivery. The Texas Department of Health and Human Services began screening newborns for Spinal Muscular Atrophy (SMA) in June 2021.

A few of the major primary and secondary sources referred to while preparing the report on the newborn screening market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (World Health Organization).

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the newborn screening market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global newborn screening market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the newborn screening market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Newborn Screening Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 Global PEST Analysis

5. Newborn Screening Market - Key Industry Dynamics

5.1 Key Market Drivers
- 5.1.1 Surging Government Funding for Newborn Screening
- 5.1.2 Rising Burden of Congenital Diseases
- 5.1.3 Increasing Prevalence of Newborn Disorders
5.2 Key Market Restraints
- 5.2.1 Lack of Uniformity in Newborn Screening Policies and Practices
5.3 Key Market Opportunities
- 5.3.1 Genetic Screening of Newborns
5.4 Future Trends
- 5.4.1 Integration of Machine Learning and Artificial Intelligence in Screening
5.5 Impact Analysis:

6. Newborn Screening Market - Global Market Analysis

6.1 Newborn Screening Market Revenue (US$ Mn), 2022 - 2030

7. Global Newborn Screening Market - Revenue and Forecast to 2030 - by Product Type

7.1 Overview
7.2 Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
7.3 Reagents and Assay Kits
- 7.3.1 Overview
- 7.3.2 Reagents and Assay Kits: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.3.2.1 Global Newborn Screening Market, by Reagents and Assay Kits, 2020-2030 (US$ Million)
7.4 Instruments
- 7.4.1 Overview
- 7.4.2 Instruments: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.4.2.1 Global Newborn Screening Market, by Instruments, 2020-2030 (US$ Million)

8. Global Newborn Screening Market - Revenue and Forecast to 2030 - by Technology

8.1 Overview
8.2 Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Tandem Mass Spectrometry (TMS)
- 8.3.1 Overview
- 8.3.2 Tandem Mass Spectrometry (TMS): Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Molecular Assays
- 8.4.1 Overview
- 8.4.2 Molecular Assays: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Immunoassays and Enzymatic Assays
- 8.5.1 Overview
- 8.5.2 Immunoassays and Enzymatic Assays: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Pulse Oximetry Screening Technology
- 8.6.1 Overview
- 8.6.2 Pulse Oximetry Screening Technology: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Other Technologies
- 8.7.1 Overview
- 8.7.2 Other Technologies: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Newborn Screening Market - Revenue and Forecast to 2030 - by Test Type

9.1 Overview
9.2 Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
9.3 Dry Blood Spot Test
- 9.3.1 Overview
- 9.3.2 Dry Blood Spot Test: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Hearing Screen Test
- 9.4.1 Overview
- 9.4.2 Hearing Screen Test: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Critical Congenital Heart Diseases (CCHD) Test
- 9.5.1 Overview
- 9.5.2 Critical Congenital Heart Diseases (CCHD) Test: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Other Test Types
- 9.6.1 Overview
- 9.6.2 Other Test Types: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

10. Global Newborn Screening Market - Revenue and Forecast to 2030 - by End User

10.1 Overview
10.2 Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
10.3 Hospitals and Clinics
- 10.3.1 Overview
- 10.3.2 Hospitals and Clinics: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Diagnostic Laboratories
- 10.4.1 Overview
- 10.4.2 Diagnostic Laboratories: Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

11. Newborn Screening Market - Geographical Analysis

11.1 North America Newborn Screening Market, Revenue and Forecast To 2030
- 11.1.1 Overview
- 11.1.2 North America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.3 North America: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
  - 11.1.3.1 North America: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
  - 11.1.3.2 North America: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.1.4 North America: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.1.5 North America: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.1.6 North America: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.1.6.1 North America Newborn Screening Market, by Country
  - 11.1.6.2 US
    - 11.1.6.2.1 US Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.6.2.2 US: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
    - 11.1.6.2.2.1 US: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
    - 11.1.6.2.2.2 US: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    - 11.1.6.2.3 US: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    - 11.1.6.2.4 US: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    - 11.1.6.2.5 US: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.1.6.3 Canada
    - 11.1.6.3.1 Canada Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.6.3.2 Canada: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
    - 11.1.6.3.2.1 Canada: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
    - 11.1.6.3.2.2 Canada: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    - 11.1.6.3.3 Canada: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    - 11.1.6.3.4 Canada: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    - 11.1.6.3.5 Canada: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.1.6.4 Mexico
    - 11.1.6.4.1 Mexico Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.6.4.2 Mexico: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
    - 11.1.6.4.2.1 Mexico: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
    - 11.1.6.4.2.2 Mexico: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    - 11.1.6.4.3 Mexico: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    - 11.1.6.4.4 Mexico: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    - 11.1.6.4.5 Mexico: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
11.2 Europe Newborn Screening Market, Revenue and Forecast to 2030
- 11.2.1 Overview
- 11.2.2 Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.2.3 Europe: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
  - 11.2.3.1 Europe: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
  - 11.2.3.2 Europe: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.2.4 Europe: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.2.5 Europe: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.2.6 Europe: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.2.6.1 Europe Newborn Screening Market, by Country
  - 11.2.6.2 UK
    - 11.2.6.2.1 UK Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.2.6.2.2 UK: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
    - 11.2.6.2.2.1 UK: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
    - 11.2.6.2.2.2 UK: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    - 11.2.6.2.3 UK: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    - 11.2.6.2.4 UK: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    - 11.2.6.2.5 UK: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.2.6.3 Germany
    - 11.2.6.3.1 Germany Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.2.6.3.2 Germany: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
    - 11.2.6.3.2.1 Germany: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
    - 11.2.6.3.2.2 Germany: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    - 11.2.6.3.3 Germany: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    - 11.2.6.3.4 Germany: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    - 11.2.6.3.5 Germany: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.2.6.4 France
    - 11.2.6.4.1 France Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.2.6.4.2 France: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
    - 11.2.6.4.2.1 France: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
    - 11.2.6.4.2.2 France: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    - 11.2.6.4.3 France: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    - 11.2.6.4.4 France: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    - 11.2.6.4.5 France: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.2.6.5 Italy
    - 11.2.6.5.1 Italy Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.2.6.5.2 Italy: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
    - 11.2.6.5.2.1 Italy: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
    - 11.2.6.5.2.2 Italy: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    - 11.2.6.5.3 Italy: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    - 11.2.6.5.4 Italy: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    - 11.2.6.5.5 Italy: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.2.6.6 Spain
    - 11.2.6.6.1 Spain Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.2.6.6.2 Spain: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
    - 11.2.6.6.2.1 Spain: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
    - 11.2.6.6.2.2 Spain: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    - 11.2.6.6.3 Spain: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    - 11.2.6.6.4 Spain: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    - 11.2.6.6.5 Spain: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.2.6.7 Rest of Europe
    - 11.2.6.7.1 Rest of Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.2.6.7.2 Rest of Europe: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
    - 11.2.6.7.2.1 Rest of Europe: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
    - 11.2.6.7.2.2 Rest of Europe: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    - 11.2.6.7.3 Rest of Europe: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    - 11.2.6.7.4 Rest of Europe: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    - 11.2.6.7.5 Rest of Europe: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
11.3 Asia Pacific Newborn Screening Market, Revenue and Forecast to 2030
- 11.3.1 Overview
- 11.3.2 Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.3.3 Asia Pacific: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
  - 11.3.3.1 Asia Pacific: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
  - 11.3.3.2 Asia Pacific: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.3.4 Asia Pacific: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.3.5 Asia Pacific: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.3.6 Asia Pacific: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.3.6.1 Asia Pacific Newborn Screening Market, by Country
  - 11.3.6.2 China
    - 11.3.6.2.1 China Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.3.6.2.2 China: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
    - 11.3.6.2.2.1 China: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
    - 11.3.6.2.2.2 China: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    - 11.3.6.2.3 China: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    - 11.3.6.2.4 China: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    - 11.3.6.2.5 China: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.3.6.3 Japan
    - 11.3.6.3.1 Japan Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.3.6.3.2 Japan: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
    - 11.3.6.3.2.1 Japan: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
    - 11.3.6.3.2.2 Japan: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    - 11.3.6.3.3 Japan: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    - 11.3.6.3.4 Japan: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    - 11.3.6.3.5 Japan: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.3.6.4 India
    - 11.3.6.4.1 India Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.3.6.4.2 India: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
    - 11.3.6.4.2.1 India: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
    - 11.3.6.4.2.2 India: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    - 11.3.6.4.3 India: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    - 11.3.6.4.4 India: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    - 11.3.6.4.5 India: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.3.6.5 Australia
    - 11.3.6.5.1 Australia Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.3.6.5.2 Australia: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
    - 11.3.6.5.2.1 Australia: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
    - 11.3.6.5.2.2 Australia: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    - 11.3.6.5.3 Australia: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    - 11.3.6.5.4 Australia: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    - 11.3.6.5.5 Australia: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.3.6.6 South Korea
    - 11.3.6.6.1 South Korea Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.3.6.6.2 South Korea: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
    - 11.3.6.6.2.1 South Korea: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
    - 11.3.6.6.2.2 South Korea: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    - 11.3.6.6.3 South Korea: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    - 11.3.6.6.4 South Korea: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    - 11.3.6.6.5 South Korea: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.3.6.7 Rest of Asia Pacific
    - 11.3.6.7.1 Rest of Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.3.6.7.2 Rest of Asia Pacific: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
    - 11.3.6.7.2.1 Rest of Asia Pacific: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
    - 11.3.6.7.2.2 Rest of Asia Pacific: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    - 11.3.6.7.3 Rest of Asia Pacific: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    - 11.3.6.7.4 Rest of Asia Pacific: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    - 11.3.6.7.5 Rest of Asia Pacific: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
11.4 Middle East & Africa Newborn Screening Market, Revenue and Forecast to 2030
- 11.4.1 Overview
- 11.4.2 Middle East & Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.4.3 Middle East & Africa: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
  - 11.4.3.1 Middle East & Africa: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
  - 11.4.3.2 Middle East & Africa: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.4.4 Middle East & Africa: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.4.5 Middle East & Africa: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.4.6 Middle East & Africa: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.4.6.1 Middle East & Africa Newborn Screening Market, by Country
  - 11.4.6.2 Saudi Arabia
    - 11.4.6.2.1 Saudi Arabia Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.4.6.2.2 Saudi Arabia: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
    - 11.4.6.2.2.1 Saudi Arabia: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
    - 11.4.6.2.2.2 Saudi Arabia: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    - 11.4.6.2.3 Saudi Arabia: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    - 11.4.6.2.4 Saudi Arabia: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    - 11.4.6.2.5 Saudi Arabia: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.4.6.3 UAE
    - 11.4.6.3.1 UAE Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.4.6.3.2 UAE: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
    - 11.4.6.3.2.1 UAE: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
    - 11.4.6.3.2.2 UAE: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    - 11.4.6.3.3 UAE: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    - 11.4.6.3.4 UAE: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    - 11.4.6.3.5 UAE: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.4.6.4 South Africa
    - 11.4.6.4.1 South Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.4.6.4.2 South Africa: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
    - 11.4.6.4.2.1 South Africa: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
    - 11.4.6.4.2.2 South Africa: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    - 11.4.6.4.3 South Africa: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    - 11.4.6.4.4 South Africa: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    - 11.4.6.4.5 South Africa: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.4.6.5 Rest of Middle East & Africa
    - 11.4.6.5.1 Rest of Middle East & Africa Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.4.6.5.2 Rest of Middle East & Africa: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
    - 11.4.6.5.2.1 Rest of Middle East & Africa: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
    - 11.4.6.5.2.2 Rest of Middle East & Africa: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    - 11.4.6.5.3 Rest of Middle East & Africa: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    - 11.4.6.5.4 Rest of Middle East & Africa: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    - 11.4.6.5.5 Rest of Middle East & Africa: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
11.5 South & Central America Newborn Screening Market, Revenue and Forecast to 2030
- 11.5.1 Overview
- 11.5.2 South & Central America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
- 11.5.3 South & Central America: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
  - 11.5.3.1 South & Central America: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
  - 11.5.3.2 South & Central America: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
- 11.5.4 South & Central America: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.5.5 South & Central America: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
- 11.5.6 South & Central America: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.5.6.1 South & Central America Newborn Screening Market, by Country
  - 11.5.6.2 Brazil
    - 11.5.6.2.1 Brazil Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.5.6.2.2 Brazil: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
    - 11.5.6.2.2.1 Brazil: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
    - 11.5.6.2.2.2 Brazil: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    - 11.5.6.2.3 Brazil: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    - 11.5.6.2.4 Brazil: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    - 11.5.6.2.5 Brazil: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.5.6.3 Argentina
    - 11.5.6.3.1 Argentina Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.5.6.3.2 Argentina: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
    - 11.5.6.3.2.1 Argentina: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
    - 11.5.6.3.2.2 Argentina: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    - 11.5.6.3.3 Argentina: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    - 11.5.6.3.4 Argentina: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    - 11.5.6.3.5 Argentina: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.5.6.4 Rest of South & Central America
    - 11.5.6.4.1 Rest of South & Central America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.5.6.4.2 Rest of South & Central America: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
    - 11.5.6.4.2.1 Rest of South & Central America: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
    - 11.5.6.4.2.2 Rest of South & Central America: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
    - 11.5.6.4.3 Rest of South & Central America: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
    - 11.5.6.4.4 Rest of South & Central America: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
    - 11.5.6.4.5 Rest of South & Central America: Newborn Screening Market, by End User, 2020-2030 (US$ Million)

12. Newborn Screening Market-Industry Landscape

12.1 Overview
12.2 Growth Strategies in Newborn Screening Market
12.3 Organic Growth Strategies
- 12.3.1 Overview
12.4 Inorganic Growth Strategies
- 12.4.1 Overview

13. Company Profiles

13.1 LifeCell International Pvt Ltd
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Zentech SA
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Trivitron Healthcare Pvt Ltd
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 PerkinElmer Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Waters Corp
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Bio-Rad Laboratories Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Masimo Corp
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Natus Medical Inc.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Baebies Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 MRC Holland BV
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 Medtronic Plc
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms

新生児スクリーニングの市場規模および動向、世界および地域シェア、動向、成長機会分析レポート対象範囲：製品タイプ別、技術別、検査タイプ別、エンドユーザー別、地域別

Newborn Screening Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type, Technology, Test Type, End User, and Geography

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章新生児スクリーニング市場の情勢

第5章新生児スクリーニング市場-主要産業力学

第6章新生児スクリーニング市場：世界市場分析

第7章新生児スクリーニングの世界市場：収益と2030年までの予測：製品タイプ別

第8章新生児スクリーニングの世界市場：収益と2030年までの予測：技術別

第9章新生児スクリーニングの世界市場：2030年までの収益と予測：検査タイプ別

第10章新生児スクリーニングの世界市場：エンドユーザー別収益と2030年までの予測

第11章新生児スクリーニング市場：地域別分析

第12章新生児スクリーニング市場-業界情勢

第13章企業プロファイル

第14章付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Newborn Screening Market Landscape

5. Newborn Screening Market - Key Industry Dynamics

6. Newborn Screening Market - Global Market Analysis

7. Global Newborn Screening Market - Revenue and Forecast to 2030 - by Product Type

8. Global Newborn Screening Market - Revenue and Forecast to 2030 - by Technology

9. Global Newborn Screening Market - Revenue and Forecast to 2030 - by Test Type

10. Global Newborn Screening Market - Revenue and Forecast to 2030 - by End User

11. Newborn Screening Market - Geographical Analysis

12. Newborn Screening Market-Industry Landscape

13. Company Profiles

14. Appendix

新生児スクリーニングの市場規模および動向、世界および地域シェア、動向、成長機会分析レポート対象範囲：製品タイプ別、技術別、検査タイプ別、エンドユーザー別、地域別

Newborn Screening Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type, Technology, Test Type, End User, and Geography

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 新生児スクリーニング市場の情勢

第5章 新生児スクリーニング市場-主要産業力学

第6章 新生児スクリーニング市場：世界市場分析

第7章 新生児スクリーニングの世界市場：収益と2030年までの予測：製品タイプ別

第8章 新生児スクリーニングの世界市場：収益と2030年までの予測：技術別

第9章 新生児スクリーニングの世界市場：2030年までの収益と予測：検査タイプ別

第10章 新生児スクリーニングの世界市場：エンドユーザー別収益と2030年までの予測

第11章 新生児スクリーニング市場：地域別分析

第12章 新生児スクリーニング市場-業界情勢

第13章 企業プロファイル

第14章 付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Newborn Screening Market Landscape

5. Newborn Screening Market - Key Industry Dynamics

6. Newborn Screening Market - Global Market Analysis

7. Global Newborn Screening Market - Revenue and Forecast to 2030 - by Product Type

8. Global Newborn Screening Market - Revenue and Forecast to 2030 - by Technology

9. Global Newborn Screening Market - Revenue and Forecast to 2030 - by Test Type

10. Global Newborn Screening Market - Revenue and Forecast to 2030 - by End User

11. Newborn Screening Market - Geographical Analysis

12. Newborn Screening Market-Industry Landscape

13. Company Profiles

14. Appendix

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章新生児スクリーニング市場の情勢

第5章新生児スクリーニング市場-主要産業力学

第6章新生児スクリーニング市場：世界市場分析

第7章新生児スクリーニングの世界市場：収益と2030年までの予測：製品タイプ別

第8章新生児スクリーニングの世界市場：収益と2030年までの予測：技術別

第9章新生児スクリーニングの世界市場：2030年までの収益と予測：検査タイプ別

第10章新生児スクリーニングの世界市場：エンドユーザー別収益と2030年までの予測

第11章新生児スクリーニング市場：地域別分析

第12章新生児スクリーニング市場-業界情勢

第13章企業プロファイル

第14章付録